PHYRAGO
Live / Applied — Second extension granted (statement of use) (as of 25 Nov 2024)
What this means for you
Not registered yet, but its 18 Jul 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97508353
- Mark type
- Stylized text
- Filed
- 18 Jul 2022
- Published for opposition
- 03 Oct 2023
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, protein kinase inhibitors used for the treatment of some leukemias in humans
Owner
- HANDA THERAPEUTICS, LLC, SAN JOSE, CA, US
- PXMMI, LLC, MINNEAPOLIS, MN, US
- Nanocopoeia, LLC, New Brighton, MN, US
- Nanocopoeia, LLC, New Brighton, MN, US
Prosecution history
- 10 Jul 2025 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 09 Jul 2025 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 04 Jun 2025 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 28 May 2025 — WITHDRAWAL OF ATTORNEY GRANTED
- 28 May 2025 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED
- 27 May 2025 — SOU TEAS EXTENSION RECEIVED
- 03 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 25 Nov 2024 — SOU EXTENSION 2 GRANTED
- 25 Nov 2024 — SOU EXTENSION 2 FILED
- 25 Nov 2024 — SOU TEAS EXTENSION RECEIVED
- 16 May 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 15 May 2024 — SOU EXTENSION 1 GRANTED
- 15 May 2024 — SOU EXTENSION 1 FILED
- 15 May 2024 — SOU TEAS EXTENSION RECEIVED
- 28 Nov 2023 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT